News | Lung Cancer | December 22, 2017

Median Technologies Collaborating With Chinese Hospital for Lung Cancer Screening Programs

Xingtai People’s Hospital will use Median’s MediScan image analysis technology to improve nodule detection in pulmonary CT scans

Median Technologies Collaborating With Chinese Hospital for Lung Cancer Screening Programs. Dave Fornell

December 22, 2017 — Median Technologies recently announced a research collaboration agreement with Xingtai People's Hospital, Xingtai City, China. Within the frame of the agreement, Median's MediScan image analysis technology will be used to conduct lung cancer screening programs organized under the aegis of Xingtai People's Hospital in Xingtai City. These programs are critically important to improving the health of the people of Xingtai City since the incidence of and mortality associated with lung cancer have increased dramatically in China and become a nationwide public health issue, giving rise to an increased burden on patients, healthcare professionals and society.

Healthcare professionals at Xingtai People's Hospital will use MediScan for the identification and monitoring of suspicious nodules found in pulmonary computed tomography (CT) scans of asymptomatic patients. Thanks to the use of MediScan in screening programs by Xingtai People's Hospital, the population of Xingtai will have access to cutting-edge software technology based on artificial intelligence principles, specifically designed to transform the identification and management of cancer lesions found in medical images.

Median's Mediscan technology provides advanced functionalities for the automated detection, quantification and follow-up of various abnormalities, including suspicious pulmonary nodules, visible in CT images. The technology will enable Xingtai People's Hospital health professionals to optimize the detection of pulmonary nodules in screened populations, enabling earliest detection of suspicious lesions in patients. Many medical reports and scientific publications show that early detection of lung cancer greatly increases the chances for successful treatment.

For more information: www.mediantechnologies.com

Related Content

Mirada Medical Releases DLCExpert for Radiotherapy Treatment Planning
Technology | Treatment Planning | February 22, 2018
February 22, 2018 — U.K.-based medical imaging software provider Mirada Medical has released DLCExpert, the first com
Sponsored Content | Videos | Pediatric Imaging | February 22, 2018
FUJIFILM Medical Systems U.S.A., Inc. and FUJIFILM SonoSite Inc., are offering a full-suite pediatric solutions...
ECR 2018 Spotlights Artificial Intelligence and Current Radiology Trends
News | Interventional Radiology | February 21, 2018
The European Congress of Radiology (ECR) announced the theme of its 2018 annual meeting, Feb. 28-March 4 in Vienna...
Sponsored Content | Videos | Flat Panel Displays | February 21, 2018
This 5 megapixel, high-brightness color monitor has the high-definition display necessary for breast imaging.
Aidoc Introduces AI Solution for Whole-Body CT Scan Analysis
News | Artificial Intelligence | February 20, 2018
Deep learning startup company Aidoc announced what it calls the world’s first and only comprehensive, full-body...
FDA Clears Siemens Healthineers' GOKnee3D MRI Application
Technology | Magnetic Resonance Imaging (MRI) | February 19, 2018
The U.S. Food and Drug Administration (FDA) has cleared GOKnee3D, a magnetic resonance imaging (MRI) application from...
A brain MRI. Gadolinium contrast agents (GBCAs) are partly retained in the brain, raising safety concerns.
Feature | Magnetic Resonance Imaging (MRI) | February 16, 2018 | Dave Fornell
One of the biggest concerns in radiology in recent years is the safety of gadolinium-based contrast agents (GBCAs) us
Arterys Receives First FDA Clearance for Oncology Imaging Suite With Deep Learning
Technology | Artificial Intelligence | February 15, 2018
Arterys Inc. announced its fifth 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Arterys...
Sponsored Content | Videos | Imaging | February 15, 2018
David Widmann, president and CEO of Konica Minolta, looks at what the future of healthcare can bring to its customers,...
Sponsored Content | Videos | Artificial Intelligence | February 15, 2018
ITN Contributing Editor Greg Freiherr offers an overview of artificial intelligence advances at the Radiological Soci
Overlay Init